{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T10:49:52Z","timestamp":1782470992778,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H14-Koka (Gan)- 031"],"award-info":[{"award-number":["H14-Koka (Gan)- 031"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H15-Koka (Gan)-024"],"award-info":[{"award-number":["H15-Koka (Gan)-024"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H16-GanRinsho-004"],"award-info":[{"award-number":["H16-GanRinsho-004"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H17-GanRinsho-004"],"award-info":[{"award-number":["H17-GanRinsho-004"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12185-026-04178-2","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:11:35Z","timestamp":1771305095000},"page":"905-915","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of children with T-cell acute lymphoblastic leukemia treated with the JACLS T-02 protocol"],"prefix":"10.1007","volume":"123","author":[{"given":"Hisashi","family":"Ishida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souichi","family":"Suenobu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Shiwaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Miyamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tsujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiya","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiichiro","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Yumura-Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuya","family":"Usami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Kosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohide","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Moriya-Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keizo","family":"Horibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1668-274X","authenticated-orcid":false,"given":"Yoshiko","family":"Hashii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"4178_CR1","first-page":"83","volume":"64","author":"E Ward","year":"2014","unstructured":"Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64:83\u2013103.","journal-title":"CA Cancer J Clin"},{"key":"4178_CR2","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1016\/S1470-2045(19)30031-2","volume":"20","author":"DT Teachey","year":"2019","unstructured":"Teachey DT, Pui C-H. Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia. Lancet Oncol. 2019;20:e142\u201354.","journal-title":"Lancet Oncol"},{"key":"4178_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28719","author":"MA Burns","year":"2021","unstructured":"Burns MA, Place AE, Stevenson KE, Guti\u00e9rrez A, Forrest S, Pikman Y, et al. Identification of prognostic factors in childhood T\u2010cell acute lymphoblastic leukemia: results from DFCI ALL consortium protocols 05\u2010001 and 11\u2010001. Pediatr Blood Cancer. 2021. https:\/\/doi.org\/10.1002\/pbc.28719.","journal-title":"Pediatr Blood Cancer"},{"key":"4178_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1470-2045(12)70600-9","volume":"14","author":"A Vora","year":"2013","unstructured":"Vora A, Goulden N, Wade R, Mitchell C, Hancock J, Hough R, et al. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial. Lancet Oncol. 2013;14:199\u2013209.","journal-title":"Lancet Oncol"},{"key":"4178_CR5","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S1470-2045(14)70243-8","volume":"15","author":"A Vora","year":"2014","unstructured":"Vora A, Goulden N, Mitchell C, Hancock J, Hough R, Rowntree C, et al. Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial. Lancet Oncol. 2014;15:809\u201318.","journal-title":"Lancet Oncol"},{"key":"4178_CR6","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1182\/blood-2011-03-338707","volume":"118","author":"M Schrappe","year":"2011","unstructured":"Schrappe M, Valsecchi MG, Bartram CR, Schrauder A, Panzer-Gr\u00fcmayer R, M\u00f6ricke A, et al. Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood. 2011;118:2077\u201384.","journal-title":"Blood"},{"key":"4178_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41375-019-0598-2","volume":"34","author":"P Quist-Paulsen","year":"2020","unstructured":"Quist-Paulsen P, Toft N, Heyman M, Abrahamsson J, Gri\u0161kevi\u010dius L, Hallb\u00f6\u00f6k H, et al. T-cell acute lymphoblastic leukemia in patients 1\u201345 years treated with the pediatric NOPHO ALL2008 protocol. Leukemia. 2020;34:347\u201357.","journal-title":"Leukemia"},{"key":"4178_CR8","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1200\/JCO.2018.77.7250","volume":"36","author":"SS Winter","year":"2018","unstructured":"Winter SS, Dunsmore KP, Devidas M, Wood BL, Esiashvili N, Chen Z, et al. Improved survival for children and young adults with T-lineage acute lymphoblastic leukemia: results from the Children\u2019s Oncology Group AALL0434 methotrexate randomization. J Clin Oncol. 2018;36:2926\u201334.","journal-title":"J Clin Oncol"},{"key":"4178_CR9","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.1016\/S2352-3026(23)00072-8","volume":"10","author":"A Sato","year":"2023","unstructured":"Sato A, Hatta Y, Imai C, Oshima K, Okamoto Y, Deguchi T, et al. Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group. Lancet Haematol. 2023;10:e419\u201332.","journal-title":"Lancet Haematol"},{"key":"4178_CR10","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1200\/JCO.21.02678","volume":"40","author":"DT Teachey","year":"2022","unstructured":"Teachey DT, Devidas M, Wood BL, Chen Z, Hayashi RJ, Hermiston ML, et al. Children\u2019s Oncology Group Trial AALL1231: a phase III clinical trial testing bortezomib in newly diagnosed T-cell acute lymphoblastic leukemia and lymphoma. J Clin Oncol. 2022;40:2106\u201318.","journal-title":"J Clin Oncol"},{"key":"4178_CR11","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1200\/JCO.19.01692","volume":"37","author":"S Jeha","year":"2019","unstructured":"Jeha S, Pei D, Choi J, Cheng C, Sandlund JT, Coustan-Smith E, et al. Improved CNS control of childhood acute lymphoblastic leukemia without cranial irradiation: St Jude total therapy study 16. J Clin Oncol. 2019;37:3377\u201391.","journal-title":"J Clin Oncol"},{"key":"4178_CR12","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s12185-014-1585-z","volume":"99","author":"R Kobayashi","year":"2014","unstructured":"Kobayashi R, Takimoto T, Nakazawa A, Fujita N, Akazai A, Yamato K, et al. Inferior outcomes of stage III T lymphoblastic lymphoma relative to stage IV lymphoma and T-acute lymphoblastic leukemia: long-term comparison of outcomes in the JACLS NHL T-98 and ALL T-97 protocols. Int J Hematol. 2014;99:743\u20139.","journal-title":"Int J Hematol"},{"key":"4178_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/MPH.0000000000000760","volume":"39","author":"K Horibe","year":"2017","unstructured":"Horibe K, Yumura-Yagi K, Kudoh T, Nishimura S, Oda M, Yoshida M, et al. Long-term results of the risk-adapted treatment for childhood B-cell acute lymphoblastic leukemia: report from the Japan Association of Childhood Leukemia Study ALL-97 trial. J Pediatr Hematol Oncol. 2017;39:81\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"key":"4178_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41408-020-0287-4","volume":"10","author":"D Hasegawa","year":"2020","unstructured":"Hasegawa D, Imamura T, Yumura-Yagi K, Takahashi Y, Usami I, Suenobu S, et al. Risk-adjusted therapy for pediatric non-T cell ALL improves outcomes for standard risk patients: results of JACLS ALL-02. Blood Cancer J. 2020;10:23.","journal-title":"Blood Cancer J"},{"key":"4178_CR15","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1182\/blood.V97.5.1211","volume":"97","author":"LB Silverman","year":"2001","unstructured":"Silverman LB, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91\u201301. Blood. 2001;97:1211\u20138.","journal-title":"Blood"},{"key":"4178_CR16","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1111\/bjh.18745","volume":"201","author":"H Ishida","year":"2023","unstructured":"Ishida H, Imamura T, Tatebe Y, Ishihara T, Sakaguchi K, Suenobu S, et al. Impact of asparaginase discontinuation on outcomes of children with acute lymphoblastic leukaemia receiving the Japan Association of Childhood Leukaemia Study ALL-02 protocol. Br J Haematol. 2023;201:1200\u20138.","journal-title":"Br J Haematol"},{"key":"4178_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/pbc.22217","volume":"54","author":"N Suzuki","year":"2010","unstructured":"Suzuki N, Yumura-Yagi K, Yoshida M, Hara J, Nishimura S, Kudoh T, et al. Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia study (JACLS) ALL F-protocol. Pediatr Blood Cancer. 2010;54:71\u20138.","journal-title":"Pediatr Blood Cancer"},{"key":"4178_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"4178_CR19","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1200\/JCO.1994.12.4.740","volume":"12","author":"MA Schorin","year":"1994","unstructured":"Schorin MA, Blattner S, Gelber RD, Tarbell NJ, Donnelly M, Dalton V, et al. Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute\/Children\u2019s Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85\u201301. J Clin Oncol. 1994;12:740\u20137.","journal-title":"J Clin Oncol"},{"key":"4178_CR20","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1182\/blood.V84.9.3122.3122","volume":"84","author":"A Reiter","year":"1994","unstructured":"Reiter A, Schrappe M, Ludwig W, Hiddemann W, Sauter S, Henze G, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood. 1994;84:3122\u201333.","journal-title":"Blood"},{"key":"4178_CR21","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1182\/blood-2007-02-070342","volume":"111","author":"NL Seibel","year":"2008","unstructured":"Seibel NL, Steinherz PG, Sather HN, Nachman JB, Delaat C, Ettinger LJ, et al. Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia\u202f: a report from the Children\u2019 s Oncology Group. Blood. 2008;111:2548\u201356.","journal-title":"Blood"},{"key":"4178_CR22","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/leu.2009.261","volume":"24","author":"WL Salzer","year":"2010","unstructured":"Salzer WL, Devidas M, Carroll WL, Winick N, Pullen J, Hunger SP, et al. Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984\u20132001: a report from the children\u2019s oncology group. Leukemia. 2010;24:355\u201370.","journal-title":"Leukemia"},{"key":"4178_CR23","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1182\/blood.V124.21.3702.3702","volume":"124","author":"K Patrick","year":"2014","unstructured":"Patrick K, Wade R, Goulden N, Mitchell C, Rowntree C, Hancock J, et al. Improved outcome for children and young people with T-acute lymphoblastic leukaemia: results of the UKALL 2003 trial. Blood. 2014;124:3702\u20133702.","journal-title":"Blood"},{"key":"4178_CR24","doi-asserted-by":"publisher","first-page":"5168","DOI":"10.1200\/JCO.2008.20.8934","volume":"27","author":"G Basso","year":"2009","unstructured":"Basso G, Veltroni M, Valsecchi MG, Dworzak MN, Ratei R, Silvestri D, et al. Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow. J Clin Oncol. 2009;27:5168\u201374.","journal-title":"J Clin Oncol"},{"key":"4178_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/sj.leu.2401310","volume":"13","author":"M Amylon","year":"1999","unstructured":"Amylon M, Shuster J, Pullen J, Berard C, Link M, Wharam M, et al. Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia. 1999;13:335\u201342.","journal-title":"Leukemia"},{"key":"4178_CR26","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1182\/blood-2010-06-292615","volume":"118","author":"BL Asselin","year":"2011","unstructured":"Asselin BL, Devidas M, Wang C, Pullen J, Borowitz MJ, Hutchison R, et al. Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children\u2019s Oncology Group (POG 9404). Blood. 2011;118:874\u201383.","journal-title":"Blood"},{"key":"4178_CR27","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1002\/cncr.34150","volume":"128","author":"S Gupta","year":"2022","unstructured":"Gupta S, Teachey DT, Chen Z, Rabin KR, Dunsmore KP, Larsen EC, et al. Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children\u2019s Oncology Group report. Cancer. 2022;128:1863\u201370.","journal-title":"Cancer"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04178-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04178-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04178-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T10:08:33Z","timestamp":1782468513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-026-04178-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4178"],"URL":"https:\/\/doi.org\/10.1007\/s12185-026-04178-2","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"26 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}